DK1432407T3 - Lisinoprilpræparater, der har DCPD med store partikler - Google Patents
Lisinoprilpræparater, der har DCPD med store partiklerInfo
- Publication number
- DK1432407T3 DK1432407T3 DK02758654T DK02758654T DK1432407T3 DK 1432407 T3 DK1432407 T3 DK 1432407T3 DK 02758654 T DK02758654 T DK 02758654T DK 02758654 T DK02758654 T DK 02758654T DK 1432407 T3 DK1432407 T3 DK 1432407T3
- Authority
- DK
- Denmark
- Prior art keywords
- lisinopril
- dcpd
- preparations
- large particles
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/962,429 US6462022B1 (en) | 2001-09-24 | 2001-09-24 | Lisinopril compositions having large-particle DCPD |
PCT/GB2002/004292 WO2003026622A1 (en) | 2001-09-24 | 2002-09-20 | Lisinopril compositions having large-particle dcpd |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1432407T3 true DK1432407T3 (da) | 2005-05-23 |
Family
ID=25505851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02758654T DK1432407T3 (da) | 2001-09-24 | 2002-09-20 | Lisinoprilpræparater, der har DCPD med store partikler |
Country Status (10)
Country | Link |
---|---|
US (1) | US6462022B1 (da) |
EP (1) | EP1432407B2 (da) |
JP (1) | JP4084749B2 (da) |
AT (1) | ATE290370T1 (da) |
DE (1) | DE60203192T3 (da) |
DK (1) | DK1432407T3 (da) |
ES (1) | ES2236561T5 (da) |
GB (1) | GB2384429B (da) |
PT (1) | PT1432407E (da) |
WO (1) | WO2003026622A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070196477A1 (en) * | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly dissolving tablets comprising low surface area calcium phosphates |
JP4925835B2 (ja) | 2007-01-12 | 2012-05-09 | 日東電工株式会社 | 物質検知センサ |
US20180325813A1 (en) | 2015-11-07 | 2018-11-15 | Ftf Pharma Private Limited | Oral solution of ace inhibitors |
GB2595203A (en) | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4517179A (en) * | 1983-04-29 | 1985-05-14 | Pennwalt Corporation | Rapid dissolving, uniform drug compositions and their preparation |
US4707361A (en) * | 1985-08-02 | 1987-11-17 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
US4675188A (en) * | 1985-08-02 | 1987-06-23 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
HU222489B1 (hu) † | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
AU6946198A (en) * | 1997-04-01 | 1998-10-22 | Cap Biotechnology, Inc. | Calcium phosphate microcarriers and microspheres |
US6117451A (en) * | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
-
2001
- 2001-09-24 US US09/962,429 patent/US6462022B1/en not_active Expired - Lifetime
-
2002
- 2002-09-20 GB GB0311750A patent/GB2384429B/en not_active Expired - Fee Related
- 2002-09-20 JP JP2003530259A patent/JP4084749B2/ja not_active Expired - Fee Related
- 2002-09-20 PT PT02758654T patent/PT1432407E/pt unknown
- 2002-09-20 AT AT02758654T patent/ATE290370T1/de active
- 2002-09-20 DE DE60203192T patent/DE60203192T3/de not_active Expired - Lifetime
- 2002-09-20 EP EP02758654A patent/EP1432407B2/en not_active Expired - Lifetime
- 2002-09-20 ES ES02758654T patent/ES2236561T5/es not_active Expired - Lifetime
- 2002-09-20 WO PCT/GB2002/004292 patent/WO2003026622A1/en active IP Right Grant
- 2002-09-20 DK DK02758654T patent/DK1432407T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1432407B1 (en) | 2005-03-09 |
ES2236561T5 (es) | 2012-10-30 |
DE60203192T3 (de) | 2012-12-27 |
EP1432407A1 (en) | 2004-06-30 |
JP4084749B2 (ja) | 2008-04-30 |
JP2005504803A (ja) | 2005-02-17 |
US6462022B1 (en) | 2002-10-08 |
ATE290370T1 (de) | 2005-03-15 |
WO2003026622A1 (en) | 2003-04-03 |
ES2236561T3 (es) | 2005-07-16 |
GB2384429A (en) | 2003-07-30 |
GB2384429B (en) | 2004-04-14 |
GB0311750D0 (en) | 2003-06-25 |
DE60203192D1 (de) | 2005-04-14 |
EP1432407B2 (en) | 2012-08-01 |
DE60203192T2 (de) | 2006-04-13 |
PT1432407E (pt) | 2005-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301268A2 (hu) | Eljárás porformulációk előállítására | |
DE59409568D1 (de) | Wirkstoffe und gas enthaltende mikropartikel | |
ATE232382T1 (de) | Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen | |
YU49698A (sh) | Smeše koje sadrže tetrahidrolipstatin | |
HUP0003095A2 (hu) | Tabletta alakú mosószer összesajtolt szemcsékből, valamint eljárás előállítására | |
ATE287704T1 (de) | Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür | |
PL360254A1 (en) | Pharmaceutical compositions | |
AU8452991A (en) | 1-aryl-3-pyridinyl-2-propene-1-ones | |
CA2445519A1 (en) | Method for manufacturing a low dose pharmaceutical composition | |
GB2334446A (en) | Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use | |
ATE330943T1 (de) | Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu | |
ATE254922T1 (de) | Pharmazeutische zusammensetzungen mit antimikrobieller wirkung | |
ATE486599T1 (de) | Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür | |
DK1432407T3 (da) | Lisinoprilpræparater, der har DCPD med store partikler | |
ATE344026T1 (de) | Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant | |
MD2722B2 (ro) | Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei | |
LV11818A (lv) | Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai | |
ES2174734A1 (es) | Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones. | |
DE60312670D1 (de) | Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie | |
ATE44467T1 (de) | Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes. | |
FI914410A0 (fi) | Kalciumupptagande inhibitorer. | |
CA2122478A1 (en) | Unit Dose Form of Bismuth Subsalicylate | |
HUP0203587A2 (hu) | Mosószerkészítmény és előállítása | |
JP2006117544A (ja) | 塩酸アンブロキソール含有内服用固形製剤 | |
DE69636983D1 (de) | Stoffe und zusammensetzungen für die verabreichung aktiver substanzen |